BIOA vs TT · rev $9.0M vs P/E 36, rev $21.32B
BioAge Labs, Inc (BIOA) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
BIOA currently screens at market cap $697.9M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the BIOA and TT stock pages for the full models.
Not investment advice.